Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
Marksans Pharma announced the final approval of the Company's wholly owned subsidiary Marksans Pharma Inc.'s Abbreviated New Drug Application (ANDA) for
Omeprazole Delayed-Release Tablets, 20 mg (OTC).
This product is bioequivalent to the reference listed drug (RLD), Prilosec Delayed-Release Tablets, 20 mg (OTC), of AstraZeneca Pharmaceuticals LP, NDA - 021229.
Omeprazole is used to treat heartburn and certain other conditions caused by too much acid in the stomach.
Cyient Semiconductors enters strategic channel partnership with Global Foundries
7 Aug 2025, 1:21PMLTIMindtree gets Rs. 792 crore PAN 2.0 project
7 Aug 2025, 11:35AMIndian stock markets close lower after fresh tariffs on India.
31-07-2025 16:44:16Q1 earnings for the Quarter ended June 30, 2025
31-07-2025 14:59:49Aurobindo Pharma arm to acquire 100% stake in Lannett Company LLC for $250 million
31-07-2025 12:02:28Budget 2024 Analysis
